-
1
-
-
0018097960
-
Quantitation of differential sensitivity of human-tumor stem cells to anticancer
-
Salmon SE, Hamburger AW, Soehnlen B, et al: Quantitation of differential sensitivity of human-tumor stem cells to anticancer. N Engl J Med 298:1321-1327, 1978
-
(1978)
N Engl J Med
, vol.298
, pp. 1321-1327
-
-
Salmon, S.E.1
Hamburger, A.W.2
Soehnlen, B.3
-
2
-
-
0019367761
-
Estimation of differential in vitro sensitivity of non-Hodgkin lymphomas to anticancer drugs
-
Sanfilippo O, Daidone MG, Costa A, et al: Estimation of differential in vitro sensitivity of non-Hodgkin lymphomas to anticancer drugs. Eur J Cancer 17:217-226, 1981
-
(1981)
Eur J Cancer
, vol.17
, pp. 217-226
-
-
Sanfilippo, O.1
Daidone, M.G.2
Costa, A.3
-
3
-
-
0020684733
-
A novel dye exclusion method for testing in vitro chemosensitivity of human tumors
-
Weisenthal LM, Marsden JA, Dill PL, et al: A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res 43:749-757, 1983
-
(1983)
Cancer Res
, vol.43
, pp. 749-757
-
-
Weisenthal, L.M.1
Marsden, J.A.2
Dill, P.L.3
-
4
-
-
0023158779
-
Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of radiosensitivity
-
Carmichael J, DeGraff WG, Gazdar AF, et al: Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of radiosensitivity. Cancer Res 47:943-946, 1987
-
(1987)
Cancer Res
, vol.47
, pp. 943-946
-
-
Carmichael, J.1
DeGraff, W.G.2
Gazdar, A.F.3
-
5
-
-
0023723711
-
In vitro testing of chemotherapeutic combinations in a rapid thymidine incorporation assay
-
Sondak VK, Korn EL, Kern DH: In vitro testing of chemotherapeutic combinations in a rapid thymidine incorporation assay. Int J Cell Cloning 6:378-391, 1988
-
(1988)
Int J Cell Cloning
, vol.6
, pp. 378-391
-
-
Sondak, V.K.1
Korn, E.L.2
Kern, D.H.3
-
6
-
-
0021544086
-
Predictive testing with the subrenal capsule assay
-
Bogden AE, Griffin W, Reich SD, et al: Predictive testing with the subrenal capsule assay. Cancer Treat Rev 11:113-124, 1984 (suppl A)
-
(1984)
Cancer Treat Rev
, vol.11
, Issue.SUPPL. A
, pp. 113-124
-
-
Bogden, A.E.1
Griffin, W.2
Reich, S.D.3
-
7
-
-
0027131204
-
Response of small-cell lung cancer xenografts to chemotherapy: Multidrug resistance and direct clinical correlates
-
Poupon MF, Arvelo F, Goguel AF, et al: Response of small-cell lung cancer xenografts to chemotherapy: Multidrug resistance and direct clinical correlates. J Natl Cancer Inst 85:2023-2029, 1993
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 2023-2029
-
-
Poupon, M.F.1
Arvelo, F.2
Goguel, A.F.3
-
8
-
-
0002858680
-
In vitro determination of drug response: A discussion of clinical applications
-
DeVita VT Jr, Hellman S, Rosenberg SA (eds): Philadelphia, PA, JB Lippincott
-
Fruehauf JP, Bosanquet AG: In vitro determination of drug response: A discussion of clinical applications, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Principles and Practice of Oncology Updates (ed 4). Philadelphia, PA, JB Lippincott, 1993, pp 1-16
-
(1993)
Principles and Practice of Oncology Updates (Ed 4)
, pp. 1-16
-
-
Fruehauf, J.P.1
Bosanquet, A.G.2
-
9
-
-
0029125017
-
Chemosensitivity and chemoresistance assays: Are they clinically relevant?
-
Markman M: Chemosensitivity and chemoresistance assays: Are they clinically relevant? J Cancer Res Clin Oncol 121:441-442, 1995
-
(1995)
J Cancer Res Clin Oncol
, vol.121
, pp. 441-442
-
-
Markman, M.1
-
10
-
-
0029990074
-
Tumor chemosensitivity and chemoresistance assay
-
Markman M, Brown E: Tumor chemosensitivity and chemoresistance assay. Cancer 77:1020-1025, 1996
-
(1996)
Cancer
, vol.77
, pp. 1020-1025
-
-
Markman, M.1
Brown, E.2
-
11
-
-
0025125820
-
Correlation of in vitro drug-sensitivity testing with response to chemotherapy and survival in extensive-stage small cell lung cancer: A prospective clinical trial
-
Gazdar AF, Steinberg SM, Russell EK, et al: Correlation of in vitro drug-sensitivity testing with response to chemotherapy and survival in extensive-stage small cell lung cancer: A prospective clinical trial. J Natl Cancer Inst 82:117-124, 1990
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 117-124
-
-
Gazdar, A.F.1
Steinberg, S.M.2
Russell, E.K.3
-
12
-
-
0028149937
-
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer
-
Ihde DC, Mulshine JL, Kramer BS, et al: Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 12:2022-2034, 1994
-
(1994)
J Clin Oncol
, vol.12
, pp. 2022-2034
-
-
Ihde, D.C.1
Mulshine, J.L.2
Kramer, B.S.3
-
13
-
-
12044258548
-
Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing
-
Shaw GL, Gazdar AF, Phelps R, et al: Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. Cancer Res 53:5181-5187, 1993
-
(1993)
Cancer Res
, vol.53
, pp. 5181-5187
-
-
Shaw, G.L.1
Gazdar, A.F.2
Phelps, R.3
-
14
-
-
0030921383
-
Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing
-
Cortazar P, Gazdar AF, Woods E, et al: Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing. Clin Cancer Res 3:741-747, 1997
-
(1997)
Clin Cancer Res
, vol.3
, pp. 741-747
-
-
Cortazar, P.1
Gazdar, A.F.2
Woods, E.3
-
15
-
-
0023315354
-
The medical review article: State of the science
-
Mulrow C: The medical review article: State of the science. Ann Intern Med 106:485-488, 1987
-
(1987)
Ann Intern Med
, vol.106
, pp. 485-488
-
-
Mulrow, C.1
-
16
-
-
0028126590
-
Users' guides to the medical literature: VI. How to use an overview - Evidence-Based Medicine Working Group
-
Oxman AD, Cook DJ, Guyatt GH: Users' guides to the medical literature: VI. How to use an overview - Evidence-Based Medicine Working Group [see comments]. JAMA 272:1367-1371, 1994
-
(1994)
JAMA
, vol.272
, pp. 1367-1371
-
-
Oxman, A.D.1
Cook, D.J.2
Guyatt, G.H.3
-
17
-
-
0002759119
-
Methodologic guidelines for review papers
-
Weed D: Methodologic guidelines for review papers. J Natl Cancer Inst 89:6-7, 1997
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 6-7
-
-
Weed, D.1
-
18
-
-
0021690379
-
Human tumor stem cell assay: A prospective clinical trial
-
Alonso K: Human tumor stem cell assay: A prospective clinical trial. Cancer 54:2475-2479, 1984
-
(1984)
Cancer
, vol.54
, pp. 2475-2479
-
-
Alonso, K.1
-
19
-
-
0029002594
-
The subrenal capsule assay in selecting chemotherapy for ovarian cancer: A prospective randomized trial
-
Maenpaa JU, Heinonen E, Hinkka SM, et al: The subrenal capsule assay in selecting chemotherapy for ovarian cancer: A prospective randomized trial. Gynecol Oncol 57:294-298, 1995
-
(1995)
Gynecol Oncol
, vol.57
, pp. 294-298
-
-
Maenpaa, J.U.1
Heinonen, E.2
Hinkka, S.M.3
-
20
-
-
0019785744
-
Chemotherapy of ovarian cancer directed by the human tumor stem cell assay
-
Alberts DS, Chen HS, Salmon SE, et al: Chemotherapy of ovarian cancer directed by the human tumor stem cell assay. Cancer Chemother Pharmacol 6:279-285, 1981
-
(1981)
Cancer Chemother Pharmacol
, vol.6
, pp. 279-285
-
-
Alberts, D.S.1
Chen, H.S.2
Salmon, S.E.3
-
21
-
-
0020597149
-
Prospective clinical trial of a human tumor cloning system
-
Von Hoff DD, Clark GM, Stogdill BJ, et al: Prospective clinical trial of a human tumor cloning system. Cancer Res 43:1926-1931, 1983
-
(1983)
Cancer Res
, vol.43
, pp. 1926-1931
-
-
Von Hoff, D.D.1
Clark, G.M.2
Stogdill, B.J.3
-
22
-
-
0021687248
-
Relation of in vitro colony survival to clinical response in a prospective trial of single-agent chemotherapy for metastatic melanoma
-
Meyskens FLJ, Loescher L, Moon TE, et al: Relation of in vitro colony survival to clinical response in a prospective trial of single-agent chemotherapy for metastatic melanoma. J Clin Oncol 2:1223-1228, 1984
-
(1984)
J Clin Oncol
, vol.2
, pp. 1223-1228
-
-
Meyskens, F.L.J.1
Loescher, L.2
Moon, T.E.3
-
23
-
-
33646962800
-
Comparison of in vitro drug sensitivity testing results with response to chemotherapy and survival: Comparison of non-small cell lung cancer and small cell lung cancer
-
Shaw GL, Gazdar AF, Phelps R, et al: Comparison of in vitro drug sensitivity testing results with response to chemotherapy and survival: Comparison of non-small cell lung cancer and small cell lung cancer. J Cell Biochem 24:173-175, 1996
-
(1996)
J Cell Biochem
, vol.24
, pp. 173-175
-
-
Shaw, G.L.1
Gazdar, A.F.2
Phelps, R.3
-
24
-
-
0025051987
-
Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician
-
Von Hoff DD, Sandbach JF, Clark GM, et al: Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J Natl Cancer Ins 82:110-116, 1990
-
(1990)
J Natl Cancer Ins
, vol.82
, pp. 110-116
-
-
Von Hoff, D.D.1
Sandbach, J.F.2
Clark, G.M.3
-
25
-
-
0025968045
-
A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer
-
Von Hoff DD, Kronmal R, Salmon SE, et al: A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer. Cancer 67:20-27, 1991
-
(1991)
Cancer
, vol.67
, pp. 20-27
-
-
Von Hoff, D.D.1
Kronmal, R.2
Salmon, S.E.3
-
26
-
-
0025992898
-
Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay
-
Yamaue H, Tanimura H, Tsunoda T et al: Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay. Eur J Cancer 27:1258-1263, 1991
-
(1991)
Eur J Cancer
, vol.27
, pp. 1258-1263
-
-
Yamaue, H.1
Tanimura, H.2
Tsunoda, T.3
-
27
-
-
0026565780
-
Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill
-
Wilbur DW, Camacho ES, Hilliard DA, et al: Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill. Br J Cancer 65:27-32, 1992
-
(1992)
Br J Cancer
, vol.65
, pp. 27-32
-
-
Wilbur, D.W.1
Camacho, E.S.2
Hilliard, D.A.3
-
28
-
-
0026483851
-
Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay
-
Yamaue H, Tanimura H, Noguchi K, et al: Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay. Br J Cancer 66:794-799, 1992
-
(1992)
Br J Cancer
, vol.66
, pp. 794-799
-
-
Yamaue, H.1
Tanimura, H.2
Noguchi, K.3
-
29
-
-
0029870844
-
Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay
-
Yamaue H, Tanimura H, Nakamori M, et al: Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay. Dis Colon Rectum 39:416-422, 1996
-
(1996)
Dis Colon Rectum
, vol.39
, pp. 416-422
-
-
Yamaue, H.1
Tanimura, H.2
Nakamori, M.3
-
30
-
-
0017785769
-
Primary bioassay of human tumor stem cells
-
Hamburger A, Salmon S: Primary bioassay of human tumor stem cells. Science 197:461-463, 1977
-
(1977)
Science
, vol.197
, pp. 461-463
-
-
Hamburger, A.1
Salmon, S.2
-
31
-
-
0020700343
-
Send this patient's tumor for culture and sensitivity
-
Von Hoff DD: Send this patient's tumor for culture and sensitivity. N Engl J Med 308:154, 1983
-
(1983)
N Engl J Med
, vol.308
, pp. 154
-
-
Von Hoff, D.D.1
-
32
-
-
0031039517
-
In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: Preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabine
-
Jense P, Holm B, Sorensen M, et al: In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: Preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabine. Br J Cancer 75:869-877, 1996
-
(1996)
Br J Cancer
, vol.75
, pp. 869-877
-
-
Jense, P.1
Holm, B.2
Sorensen, M.3
-
33
-
-
0030019658
-
Cytotoxic effects of gemcitabine containing regimens against human non-small cell lung cancer cell lines which express different levels of p185
-
Tsai C, Chang K, Chen J, et al: Cytotoxic effects of gemcitabine containing regimens against human non-small cell lung cancer cell lines which express different levels of p185. Cancer Res 56:794-801, 1996
-
(1996)
Cancer Res
, vol.56
, pp. 794-801
-
-
Tsai, C.1
Chang, K.2
Chen, J.3
-
34
-
-
0028020890
-
Phase II study of gemcitabine (2',2'-Difluorodeoxycytidine) in previously treated ovarian cancer patients
-
Lund B, Hansen O, Theilade K, et al: Phase II study of gemcitabine (2',2'-Difluorodeoxycytidine) in previously treated ovarian cancer patients. J Natl Cancer Inst 86:1530-1533, 1994
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 1530-1533
-
-
Lund, B.1
Hansen, O.2
Theilade, K.3
-
35
-
-
0028078681
-
Dose intense taxol: High dose response rate in patients with platinum-resistance recurrent ovarian cancer
-
Kohn EC, Sarosy G, Bicher A, et al: Dose intense taxol: High dose response rate in patients with platinum-resistance recurrent ovarian cancer. J Natl Cancer Inst 86:18-24, 1994
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 18-24
-
-
Kohn, E.C.1
Sarosy, G.2
Bicher, A.3
-
36
-
-
0029054486
-
Paclitaxel as second and subsequent therapy for metastatic breast cancer: Activity independent of prior anthracycline response
-
Seidman AD, Reichman BS, Crown JP, et al: Paclitaxel as second and subsequent therapy for metastatic breast cancer: Activity independent of prior anthracycline response. J Clin Oncol 13:1152-1159, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 1152-1159
-
-
Seidman, A.D.1
Reichman, B.S.2
Crown, J.P.3
-
37
-
-
0030996375
-
Paclitaxel for breast cancer: The Memorial Sloan-Kettering Cancer Center experience
-
Seidman AD, Hudis CA, Raptis G, et al: Paclitaxel for breast cancer: The Memorial Sloan-Kettering Cancer Center experience. Oncology 11:20-28, 1997
-
(1997)
Oncology
, vol.11
, pp. 20-28
-
-
Seidman, A.D.1
Hudis, C.A.2
Raptis, G.3
-
38
-
-
0028824166
-
Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer
-
Ravdin P, Burris HA, Cook G, et al: Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer. J Clin Oncol 13:2879-2885, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 2879-2885
-
-
Ravdin, P.1
Burris, H.A.2
Cook, G.3
-
39
-
-
0028827482
-
Phase II trial of docetaxel: A new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer
-
Valero V, Holmes FA, Walters RS, et al: Phase II trial of docetaxel: A new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer. J Clin Oncol 13:2886-2894, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 2886-2894
-
-
Valero, V.1
Holmes, F.A.2
Walters, R.S.3
-
40
-
-
0030740432
-
Management strategies for recurrent non-small cell lung cancer
-
Fosella FV, Lee JS, Hong WK: Management strategies for recurrent non-small cell lung cancer. Semin Oncol 24:455-462, 1997
-
(1997)
Semin Oncol
, vol.24
, pp. 455-462
-
-
Fosella, F.V.1
Lee, J.S.2
Hong, W.K.3
-
41
-
-
0028944053
-
Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer
-
Fosella FV, Lee LS, Shin DM, et al: Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer. J Clin Oncol 13:645-651, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 645-651
-
-
Fosella, F.V.1
Lee, L.S.2
Shin, D.M.3
|